BioThrust is a bioprocessing startup based in Germany that brings modern ATMP production to industrial scales. Our bionic bioreactor employs a revolutionary gas transfer technology, enabling stress-free, bubble-free cultivation conditions at world record cell concentrations with excellent quality. For example, benchmark runs have shown +200% stem cell yield (iPSCs) and +400% mAb yield from CHO cells. In both cases against a thoroughly optimized conventional bioreactor process. By efficiently scaling the cell cultivation at high intensity, we help make cutting edge therapeutic products more affordable through reducing manufacturing costs / COGS.
| Website | https://biothrust.com |
| Employees | 31 (13 on RocketReach) |
| Founded | 2022 |
| Industry | Biotechnology Research |
| Competitors | Thermo Fisher Scientific, SGS, Agilent Technologies, MilliporeSigma, Eurofins, PerkinElmer, Inc., Waters Corporation, Pall Corporation, Bio-Rad Laboratories, VWR, part of Avantor +40 more (view full list) |
Looking for a particular BioThrust employee's phone or email?
Patrick Bongartz is the Co-Founder and CEO of BioThrust.
13 people are employed at BioThrust.